NASDAQ:CDXC
ChromaDex Corporation Stock News
$3.44
+0.0500 (+1.47%)
At Close: Apr 26, 2024
CDXC Stock Price Increases Over 20% Pre-Market: Why It Happened
09:16am, Wednesday, 10'th Mar 2021
The stock price of Chromadex Corp (Nasdaq: CDXC) is trading at above 20% pre-market. This is why it happened.
ChromaDex Announces Retail Distribution of Tru Niagen® in Walmart Stores Across the United States
06:34am, Wednesday, 10'th Mar 2021
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #healthyaging--ChromaDex Corp. (NASDAQ:CDXC) announced today its flagship consumer product and industry-leading NAD+ booster Tru Niagen® will be available in 3,
ChromaDex to Present at Oppenheimer 31st Annual Healthcare Conference
06:32am, Tuesday, 09'th Mar 2021
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #HealthyAging--ChromaDex Corp. (NASDAQ: CDXC) is scheduled to participate in a virtual presentation at the Oppenheimer 31st Annual Healthcare Conference on Wedne
ChromaDex (CDXC) Surges 12%: Is This an Indication of Further Gains?
09:51am, Monday, 08'th Mar 2021
ChromaDex (CDXC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r
ChromaDex Appoints Preventative Medicine Specialist Dr. David L. Katz to its Scientific Advisory Board
06:31am, Monday, 08'th Mar 2021
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #CellularHealth--ChromaDex Corp. (NASDAQ:CDXC) announced today it has appointed David L. Katz, MD, MPH, FACPM, FACP, FACLM - CEO of Diet ID, Inc, founder and for
ChromaDex (CDXC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
01:38pm, Wednesday, 03'rd Mar 2021
ChromaDex (CDXC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CDX Stock Price Increased 92.4%: Why It Happened
06:09am, Friday, 26'th Feb 2021
The stock price of ChromaDex Corp. (NASDAQ: CDXC) increased by 92.4% on Thursday, February 25. This is why it happened.
Why ChromaDex Shares Spiked 111% Today
09:57pm, Thursday, 25'th Feb 2021
Chromadex Corp (NASDAQ: CDXC) shares jumped 111% in the regular and after-hours sessions today. What Happened: The price movement on Thursday was accompanied by intense trading with volumes of 116.67
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #COVID19research--ChromaDex Corp. (NASDAQ: CDXC) today announced results from the study “Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate
CDXC Stock Price Increased 15.64%: Why It Happened
03:23am, Tuesday, 23'rd Feb 2021
The stock price of Chromadex Corp (NASDAQ: CDXC) increased by 15.64%. This is why it happened.
ChromaDex Raises $25M Via Equity At 22% Discount
07:17am, Monday, 22'nd Feb 2021
ChromaDex Corp (NASDAQ: CDXC) enters into a securities purchase agreement to sell $25 million in common stock via a private placement led by a new international investor. The company will sell aro
ChromaDex Announces $25 Million Private Placement of Common Stock
06:30am, Monday, 22'nd Feb 2021
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #CellularHealth--ChromaDex Corp. (NASDAQ: CDXC) announced today that it has entered into a securities purchase agreement for the sale of $25.0 million of its com
ChromaDex to Report Fourth Quarter 2020 Financial Results on Wednesday, March 10, 2021
06:35am, Friday, 19'th Feb 2021
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #CellularHealth--ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Wed., March 10, 2021 at 4:30 p.m. ET to discuss its financial res
This Bioscience Company Is Trying To Defy The Aging Process
01:13pm, Friday, 12'th Feb 2021
ChromaDex was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, 2020. The information contained in this article in no way represents investment advice o
New Study Results Finds Nutritional Protocol Including Nicotinamide Riboside Reduces Liver Fat and Improves Liver Function
06:35am, Thursday, 04'th Feb 2021
LOS ANGELES--(BUSINESS WIRE)---- $CDXC #CellularHealth--ChromaDex Corp. (NASDAQ: CDXC) today announced results from the study “Combined Metabolic Cofactor Supplementation Reduces Liver Fat in Nonalc
